Among the enriched MFs, the lipopolysaccharide (LPS) immune receptor activity driven by TLR2 hub-DEG is associated with the LPS-induced production of pro-inflammatory cytokines reduction, inflammation by affecting the lungs LPS due to the COVID-19 infection56–58. The gene discussed is TLR2; the disease is COVID-19.